Avidity Partners Management’s Medicus Sciences Acquisition Corp MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-520,000
Closed -$5.24M – 106
2022
Q4
$5.24M Hold
520,000
– – 0.11% 66
2022
Q3
$5.15M Hold
520,000
– – 0.1% 76
2022
Q2
$5.09M Hold
520,000
– – 0.12% 59
2022
Q1
$5.09M Hold
520,000
– – 0.11% 71
2021
Q4
$5.04M Hold
520,000
– – 0.11% 76
2021
Q3
$5.07M Hold
520,000
– – 0.11% 83
2021
Q2
$5.02M Buy
+520,000
New +$5.08M 0.14% 89

Avidity Partners Management's MSAC Position: Q1 2023 in Review

Avidity Partners Management sold out of Medicus Sciences Acquisition Corp (MSAC) in Q1 2023, closing a stake of 520,000 shares — an estimated $5.24M sold.

Avidity Partners Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $5.24M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

  • Avidity Partners Management reported no remaining Medicus Sciences Acquisition Corp position as of Q1 2023 after selling out during the quarter.
  • Avidity Partners Management sold 520,000 Medicus Sciences Acquisition Corp shares in Q1 2023, an estimated $5.24M.
  • Avidity Partners Management first reported a position in Medicus Sciences Acquisition Corp in Q2 2021 and held it in 7 quarters.
  • Avidity Partners Management's Medicus Sciences Acquisition Corp position peaked at $5.24M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp as of Q1 2023.

Based on Avidity Partners Management's 13F filing for Q1 2023, filed 15 May 2023.